ArticleCureus2026
Arthropod Exposure-Associated Neurogenic Pruritus: A Complex Neuro-Immune Transition Mimicking Refractory Urticaria.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic pruritus is a complex and often multifactorial clinical condition that may evolve beyond its initial inflammatory trigger, leading to significant diagnostic and therapeutic challenges. We report the case of a 45-year-old female who developed a persistent and progressively refractory pruritic disorder following arthropod exposure, clinically consistent with bedbug exposure. The condition evolved from an acute inflammatory eruption into a chronic state characterized by severe itch, evolving lesion morphology, and incomplete response to antihistamines and corticosteroids despite stepwise escalation, including leukotriene receptor antagonists and prolonged corticosteroid therapy. The presence of ecchymotic lesions early in the disease course prompted extensive hematologic and autoimmune evaluation, which was unremarkable. Over time, the clinical pattern shifted toward a neurogenic phenotype with strong psychophysiologic modulation, particularly in relation to stress. The patient demonstrated significant improvement following initiation of neuromodulatory therapy with gabapentin and mirtazapine. This case emphasizes the clinical importance of early recognition of a clinically inferred neuroimmune transition to avoid ineffective therapeutic escalation and enable mechanism-based, targeted neuromodulatory management in refractory cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.